GIANNONI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 20.375
AS - Asia 12.576
EU - Europa 11.115
SA - Sud America 2.806
AF - Africa 336
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 29
Totale 47.268
Nazione #
US - Stati Uniti d'America 19.237
SG - Singapore 4.738
RU - Federazione Russa 3.453
CN - Cina 3.038
BR - Brasile 2.204
IT - Italia 2.163
VN - Vietnam 1.798
GB - Regno Unito 1.763
HK - Hong Kong 913
DE - Germania 841
CA - Canada 809
BD - Bangladesh 650
UA - Ucraina 625
FR - Francia 435
SE - Svezia 317
FI - Finlandia 272
IN - India 272
DK - Danimarca 271
AR - Argentina 224
NL - Olanda 220
MX - Messico 218
IE - Irlanda 190
IL - Israele 177
PL - Polonia 177
TR - Turchia 160
ID - Indonesia 129
EC - Ecuador 123
ES - Italia 112
PK - Pakistan 111
JP - Giappone 110
IQ - Iraq 108
ZA - Sudafrica 107
AT - Austria 70
MA - Marocco 62
UZ - Uzbekistan 60
CO - Colombia 59
VE - Venezuela 53
CL - Cile 42
LT - Lituania 41
AE - Emirati Arabi Uniti 40
PH - Filippine 36
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
TN - Tunisia 28
EG - Egitto 27
EU - Europa 27
PE - Perù 24
UY - Uruguay 23
CH - Svizzera 21
MY - Malesia 21
RO - Romania 21
NP - Nepal 20
DZ - Algeria 18
AU - Australia 17
BE - Belgio 17
HN - Honduras 17
JM - Giamaica 17
JO - Giordania 17
AZ - Azerbaigian 16
TH - Thailandia 14
KG - Kirghizistan 13
KR - Corea 13
BO - Bolivia 12
CR - Costa Rica 12
DO - Repubblica Dominicana 12
GR - Grecia 12
PS - Palestinian Territory 12
PT - Portogallo 11
CZ - Repubblica Ceca 10
NI - Nicaragua 10
NZ - Nuova Zelanda 9
PA - Panama 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
IR - Iran 6
MG - Madagascar 6
QA - Qatar 6
SV - El Salvador 6
AL - Albania 5
CG - Congo 5
GT - Guatemala 5
GY - Guiana 5
HR - Croazia 5
MT - Malta 5
NO - Norvegia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
Totale 47.166
Città #
Dallas 3.729
Singapore 2.375
Ashburn 1.485
San Jose 1.336
Beijing 1.238
Southend 907
Hong Kong 796
Chandler 734
Los Angeles 622
Moscow 597
Fairfield 585
Houston 547
Ho Chi Minh City 537
Woodbridge 469
Chicago 442
San Mateo 436
Ann Arbor 422
New York 413
Falls Church 406
Seattle 367
Hanoi 362
Cambridge 333
Jacksonville 330
Wilmington 317
The Dalles 309
Ottawa 256
Buffalo 234
São Paulo 234
Santa Clara 228
Boardman 226
Lauterbourg 224
Hefei 216
Dearborn 214
Dublin 188
Milan 180
Pisa 180
Salt Lake City 178
Rome 172
Portsmouth 170
Stevenage 164
Beauharnois 163
Orem 156
Tel Aviv 154
Warsaw 154
Munich 149
Dong Ket 147
Helsinki 142
London 140
Lawrence 132
Montreal 125
Council Bluffs 123
Brooklyn 119
Mexico City 111
Tokyo 99
Denver 97
Atlanta 92
Stockholm 92
Frankfurt am Main 88
Poplar 87
Chennai 85
Tampa 84
Toronto 80
Istanbul 77
Amsterdam 75
Johannesburg 73
Da Nang 72
Elk Grove Village 72
Florence 72
Montréal 72
Rio de Janeiro 71
Phoenix 67
Nuremberg 66
San Diego 64
Haiphong 60
Boston 57
Tashkent 55
Fremont 53
San Francisco 52
Guayaquil 48
Manchester 48
Ankara 47
Biên Hòa 45
Turku 44
Brasília 41
Mumbai 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Bologna 38
Genoa 38
Paris 37
Dongguan 36
Guangzhou 36
Baghdad 35
Curitiba 35
Naples 35
Lancaster 34
Porto Alegre 34
Quito 34
Sterling 34
Totale 27.694
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.696
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 584
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 493
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 436
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 396
A simple echocardiographic score to rule out cardiac amyloidosis 375
A simple echocardiographic score to rule out cardiac amyloidosis 345
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 344
Central sleep apnea and cardiovascular disease state-of-the-art 340
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 338
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 332
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 328
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 327
Treating chemoreflex in heart failure: modulation or demolition? 324
Prediction of the chemoreflex gain by common clinical variables in heart failure 323
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 321
[Central apneas and cardiovascular diseases] 320
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 318
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 318
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 313
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 311
Adrenergic activation in heart failure: blockade or rebalance? 308
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 305
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 305
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 298
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 296
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 293
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 292
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 288
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 287
Screening the health status of people working in a university 285
Eligibility for vericiguat in a real‐world, contemporary heart failure population 283
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 283
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 276
How to take arms against central apneas in heart failure 275
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 274
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 273
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 273
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 272
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 270
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 270
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 266
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 262
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 261
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 261
B-type natriuretic peptide secretion following scuba diving 260
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 260
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 259
null 258
null 258
Improved survival in limited scleroderma-related pulmonary artery hypertension 257
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 255
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 253
null 253
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 252
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 252
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 252
Valve disease in cardiac amyloidosis: an echocardiographic score 251
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 250
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 250
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 250
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 250
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 249
An atypical case of cardiac amyloidosis. 247
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 247
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 244
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 244
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 242
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 241
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 240
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 238
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 238
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 237
Role of Imaging in Cardiomyopathies 235
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 235
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 233
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 231
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 231
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 231
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 230
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 229
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 228
null 228
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 227
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 227
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 225
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 224
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 224
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 224
Renin profiling predicts neurohormonal response to sacubitril/valsartan 223
Prognostic value of plasma Renin activity in heart failure. 222
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 222
Breath-hold task induces temporal heterogeneity in electroencephalographic regional field power in healthy subjects 222
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 221
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 220
null 218
Reversal of ticagrelor-induced arrhythmias and cheyne-stokes respiration with aminophylline infusion 218
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 218
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 217
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 217
Totale 28.705
Categoria #
all - tutte 228.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 228.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 0 0 0 0 0 0 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202624.758 1.363 4.006 2.931 3.638 2.944 1.612 2.391 1.058 1.413 1.557 1.726 119
Totale 47.536